Skip to main content

Animations

MJFF Publications

5101 - 5110 of 6568 Results
Title
Year
  • Year
  • 2026
  • 2025
  • 2021
  • 2019
  • 2017
  • 2023
  • 2024
  • 2023
  • 2014
  • 2025
  • Summary Details
    OPEN
    Title: Quantitative measures of total and phosphorylated alpha-synuclein in skin tissue as potential biomarkers for synucleinopathies
    Journal Name: Journal of Parkinson’s Disease
    Publisher: SAGE Publications
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1177/1877718x261420669
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Direct disassembly of α-syn preformed fibrils into α-syn monomers by an all-D-peptide
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-025-01132-7
    Citation Count: 2
  • Summary Details
    OPEN
    Title: Reconstitution of cargo-induced LC3 lipidation in mammalian selective autophagy
    Journal Name: Science Advances
    Publisher: American Association for the Advancement of Science (AAAS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1126/sciadv.abg4922
    Citation Count: 55
  • Mass Spectrometric Analysis of Lewy Body-Enriched α-Synuclein in Parkinson’s Disease
    2019
    Summary Details
    OPEN
    Title: Mass Spectrometric Analysis of Lewy Body-Enriched α-Synuclein in Parkinson’s Disease
    Journal Name: Journal of Proteome Research
    Publisher: American Chemical Society (ACS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1021/acs.jproteome.8b00982
    Citation Count: 75
  • Summary Details
    OPEN
    Title: Cholinergic activity and levodopa‐induced dyskinesia: a multitracer molecular imaging study
    Journal Name: Annals of Clinical and Translational Neurology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/acn3.438
    Citation Count: 19
  • Summary Details
    OPEN
    Title: Pregnenolone for the treatment of L-DOPA-induced dyskinesia in Parkinson's disease
    Journal Name: Experimental Neurology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.expneurol.2023.114370
    Citation Count: 15
  • Summary Details
    OPEN
    Title: The Association of Antidepressant Use and Impulse Control Disorder in Parkinson's Disease
    Journal Name: The American Journal of Geriatric Psychiatry
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.jagp.2023.12.024
    Citation Count: 10
  • Summary Details
    OPEN
    Title: Leucine-rich repeat kinase 2 at a glance
    Journal Name: Journal of Cell Science
    Publisher: The Company of Biologists
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1242/jcs.259724
    Citation Count: 19
  • Summary Details
    OPEN
    Title: MMP-9 expression is increased in B lymphocytes during multiple sclerosis exacerbation and is regulated by microRNA-320a
    Journal Name: Journal of Neuroimmunology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.jneuroim.2014.11.004
    Citation Count: 64
  • Summary Details
    OPEN
    Title: Pregnenolone Reduces L‐Dopa‐Induced Dyskinesias in Female Parkinsonian Monkeys
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/mds.30280
    Citation Count: 0
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.